L. Boulay

579 total citations
15 papers, 461 citations indexed

About

L. Boulay is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, L. Boulay has authored 15 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 4 papers in Cognitive Neuroscience and 3 papers in Pharmacology. Recurrent topics in L. Boulay's work include Schizophrenia research and treatment (8 papers), Musculoskeletal pain and rehabilitation (3 papers) and Functional Brain Connectivity Studies (3 papers). L. Boulay is often cited by papers focused on Schizophrenia research and treatment (8 papers), Musculoskeletal pain and rehabilitation (3 papers) and Functional Brain Connectivity Studies (3 papers). L. Boulay collaborates with scholars based in Canada, United Kingdom and United States. L. Boulay's co-authors include Tom N. Tombaugh, Laura Rees, Émmanuel Stip, Alain Labelle, Sylvie Chouinard, Jacques P. Brown, Scot E. Purdon, Adham Mancini‐Marïe, Boualem Mensour and Pierre Bourgouin and has published in prestigious journals such as Schizophrenia Research, Alzheimer s & Dementia and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

L. Boulay

14 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Boulay Canada	9	240	126	108	91	85	15	461
Mathias Luderer Germany	10	214 0.9×	139 1.1×	50 0.5×	64 0.7×	62 0.7×	25	382
Karolina Kozak Canada	8	95 0.4×	110 0.9×	52 0.5×	107 1.2×	53 0.6×	14	374
Robert Olbrich Germany	12	194 0.8×	95 0.8×	75 0.7×	70 0.8×	100 1.2×	43	471
Ilya Reznik Israel	13	325 1.4×	121 1.0×	25 0.2×	153 1.7×	56 0.7×	32	569
Killian A. Welch United Kingdom	9	104 0.4×	99 0.8×	61 0.6×	41 0.5×	37 0.4×	11	318
G.N. Christodoulou Greece	12	191 0.8×	73 0.6×	30 0.3×	51 0.6×	63 0.7×	46	418
J. Liappas Greece	12	154 0.6×	32 0.3×	124 1.1×	77 0.8×	61 0.7×	30	464
Andrew P. Ho United States	9	314 1.3×	83 0.7×	69 0.6×	67 0.7×	57 0.7×	12	517
Antonietta Scaffidi Australia	6	113 0.5×	67 0.5×	54 0.5×	79 0.9×	63 0.7×	7	364
Fabienne Cyprien France	12	141 0.6×	170 1.3×	41 0.4×	218 2.4×	66 0.8×	24	492

Countries citing papers authored by L. Boulay

Since Specialization

Citations

This map shows the geographic impact of L. Boulay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Boulay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Boulay more than expected).

Fields of papers citing papers by L. Boulay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Boulay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Boulay. The network helps show where L. Boulay may publish in the future.

Co-authorship network of co-authors of L. Boulay

This figure shows the co-authorship network connecting the top 25 collaborators of L. Boulay. A scholar is included among the top collaborators of L. Boulay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Boulay. L. Boulay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Glass, Jennifer M., L. Boulay, Sarah Cotton, et al.. (2024). Diagnostic journey and barriers to diagnosis for patients with mild cognitive impairment or dementia due to Alzheimer’s disease in Canada: results from a real‐world survey. Alzheimer s & Dementia. 20(S8).

Brown, Jacques P. & L. Boulay. (2013). Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee. Therapeutic Advances in Musculoskeletal Disease. 5(6). 291–304. 43 indexed citations

Alaka, Karla, et al.. (2013). Safety of duloxetine for the treatment of older patients with osteoarthritis knee pain or chronic low back pain. Journal of Pain. 14(4). S61–S61. 1 indexed citations

Williamson, Owen D., et al.. (2013). Antidepressants in the Treatment for Chronic Low Back Pain: Questioning the Validity of Meta‐Analyses. Pain Practice. 14(2). E33–41. 14 indexed citations

Joyal, Christian C., Anu Putkonen, Adham Mancini‐Marïe, et al.. (2007). Violent persons with schizophrenia and comorbid disorders: A functional magnetic resonance imaging study. Schizophrenia Research. 91(1-3). 97–102. 50 indexed citations

Boulay, L., Alain Labelle, Dominique Bourget, et al.. (2007). Dissociating medication effects from learning and practice effects in a neurocognitive study of schizophrenia: Olanzapine versus haloperidol. Cognitive Neuropsychiatry. 12(4). 322–338. 8 indexed citations

Stip, Émmanuel, Marc Corbière, L. Boulay, et al.. (2007). Intrusion errors in explicit memory: Their differential relationship with clinical and social outcome in chronic schizophrenia. Cognitive Neuropsychiatry. 12(2). 112–127. 13 indexed citations

Stip, Émmanuel, Sylvie Chouinard, & L. Boulay. (2005). On the trail of a cognitive enhancer for the treatment of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(2). 219–232. 67 indexed citations

Fahim, Chérine, Émmanuel Stip, Adham Mancini‐Marïe, et al.. (2005). Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: An fMRI study. Psychiatry Research Neuroimaging. 140(1). 1–15. 65 indexed citations

10.

Labelle, Alain, et al.. (2002). Switching Outpatients With Schizophrenia and Related Disorders on Long-Acting Injectable Antipsychotics to Olanzapine: An Open-Label Naturalistic Pilot Study. Journal of Clinical Psychopharmacology. 22(6). 545–553. 7 indexed citations

11.

Purdon, Scot E., Alain Labelle, & L. Boulay. (2001). Neuropsychological change in schizophrenia after 6 weeks of clozapine. Schizophrenia Research. 48(1). 57–67. 40 indexed citations

12.

Rees, Laura, Tom N. Tombaugh, & L. Boulay. (2001). Depression and the Test of Memory Malingering. Archives of Clinical Neuropsychology. 16(5). 501–506. 127 indexed citations

13.

Labelle, Alain & L. Boulay. (1999). An attempted suicide using transdermal nicotine patches.. PubMed. 44(2). 190–1. 16 indexed citations

14.

Labelle, Alain, L. Boulay, & Y.D. Lapierre. (1999). Retention Rates in Placebo- and Nonplacebo-Controlled Clinical Trials of Schizophrenia. The Canadian Journal of Psychiatry. 44(9). 887–892. 8 indexed citations

15.

Labelle, Amber L., Renaud de Beaurepaire, L. Boulay, et al.. (1996). Efficacy, safety and tolerance of a D1 antagonist SCH 39 66 in 6 cases of acute psychotic states. Schizophrenia Research. 18(2-3). 133–133. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact